Skip to content

Azenta AZTA Investment Proceeds

Investment Proceeds at other companies

Danaher logo
DanaherDHR
$0-100%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
$29M+190%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$5M-34.6%
BioLife Solutions logo
BioLife SolutionsBLFS
$2.33M+307%
Opko Health logo
Opko HealthOPK
$0-100%
GeneDx Holdings logo
GeneDx HoldingsWGS
$875K

Other financials

Income statement

See full
Revenue$144.8M+1.0%
Gross profit$62.0M-1.2%
Operating income-$165.8M-811%
Net income-$160.8M-237%
EPS (diluted)-$3.49-236%

Balance sheet

See full
Cash & equivalents$125.2M
Total debt$55.7M
Total equity$1.6B-8.3%
Total assets$1.9B

Cash flow

See full
Operating cash flow$13.5M-6.2%
CapEx$7.4M-0.1%
Free cash flow$6.1M-12.7%

Valuation

See full
Market cap$1.1B-19.0%
Enterprise value$1.03B
P/S1.8×-0.3×

Profitability

See full
Gross margin40%-1.0pp
Operating margin-31.6%-59.7pp
Net margin-29.1%-80.7pp
FCF margin8.6%

Returns & leverage

See full
Return on equity-10.7%-22.4pp
Debt / equity
Current ratio2.8×

Where this comes from

Reported directly by Azenta in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfOtherInvestments.

The official record: Azenta’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Azenta's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Azenta's investment proceeds?
Azenta (AZTA) reported investment proceeds of -$142.66M in Q1 2026.
What is the long-term trend for Azenta's investment proceeds?
Over 2 years (2022 to 2024), Azenta's investment proceeds has grown at a -21.8% compound annual growth rate (CAGR), from $705.39M to $431.52M.
What does investment proceeds mean?
Cash received from sales, maturities, and redemptions of investment securities across all categories.